CliffBio
small molecule

FLURAZEPAM HYDROCHLORIDE

FLURAZEPAM HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyHIKMA INTERNATIONAL PHARMACEUTICALS LLC

Drug detail

Brand nameFLURAZEPAM HYDROCHLORIDE
Active ingredientFLURAZEPAM HYDROCHLORIDE
Strength30MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1986
Marketing statusDISCN

More from HIKMA INTERNATIONAL PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

FLURAZEPAM HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio